Rahmani, Azam
Fallahi, Arezoo
Allahqoli, Leila
Grylka-Baeschlin, Susanne
Alkatout, Ibrahim
Article History
Received: 13 February 2023
Accepted: 24 August 2023
First Online: 9 September 2023
Declarations
:
: The protocol was approved by the review boards of NIMAD (National Institute for Medical Research Development: 976748) in Iran and the cantonal ethics committee of Zurich (BASEC No. Req-2018-00984) in Switzerland. Informed consent was obtained from all individual participants included in the study. All methods were carried out in accordance with relevant guidelines and regulations outlined in the declaration.
: Non applicable.
: All authors declare that they have no conflict of interest.